TARGETED CLINICAL TRIALS TO REDUCE THE RISK OF ANTIMICROBIAL RESISTANCE

降低抗生素耐药性风险的有针对性的临床试验

• 批准号: 9529792
• 负责人: KEITH KAYE
• 金额: $ 850.92万
• 依托单位: UNIVERSITY OF MICHIGAN AT ANN ARBOR
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-09-01 至 2020-02-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9529792
• 关键词: Antibiotic Resistance; Antimicrobial Resistance; Clinical Trials; Drug Exposure; Gram-Negative Bacteria; Multidrug-resistant Acinetobacter; Probability; Regimen; Risk; safety testing; therapeutic effectiveness; therapeutic evaluation

To evaluate strategies that test the safety and effectiveness of therapeutic approaches/regimens to reduce the probability of the emergence of antibiotic drug resistance by minimizing unnecessary drug exposure.

评估测试治疗方法/方案的安全性和有效性的策略，以最大限度地减少不必要的药物暴露，以减少出现抗生素耐药性的可能性。